The Innovation (May 2024)

A causal multiomics study discriminates the early immune features of Ad5-vectored Ebola vaccine recipients

  • Zhe Zhang,
  • Wenjing Yang,
  • Zhengshan Chen,
  • Haoang Chi,
  • Shipo Wu,
  • Wanru Zheng,
  • Ruochun Jin,
  • Busen Wang,
  • Yudong Wang,
  • Nan Huo,
  • Jinlong Zhang,
  • Xiaohong Song,
  • Liyang Xu,
  • Jun Zhang,
  • Lihua Hou,
  • Wei Chen

Journal volume & issue
Vol. 5, no. 3
p. 100603

Abstract

Read online

The vaccine-induced innate immune response is essential for the generation of an antibody response. To date, how Ad5-vectored vaccines are influenced by preexisting anti-Ad5 antibodies during activation of the early immune response remains unclear. Here, we investigated the specific alterations in GP1,2-specific IgG-related elements of the early immune response at the genetic, molecular, and cellular levels on days 0, 1, 3, and 7 after Ad5-EBOV vaccination. In a causal multiomics analysis, distinct early immune responses associated with GP1,2-specific IgG were observed in Ad5-EBOV recipients with a low level of preexisting anti-Ad5 antibodies. This study revealed the correlates of the Ad5-EBOV-induced IgG response and provided mechanistic evidence for overcoming preexisting Ad5 immunity during the administration of Ad5-vectored vaccines.